The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Offer for Subscription

26 Sep 2018 18:29

RNS Number : 0755C
Maven Income & Growth VCT PLC
26 September 2018
 

Joint Announcement

 

Offer for Subscription

26 September 2018

The Board of Directors of Maven Income and Growth VCT PLC ("Maven VCT 1") and Maven Income and Growth VCT 5 PLC ("Maven VCT 5") (together the "Companies" and each a "Company") are pleased to announce that they have published a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares of 10p each in each of the Companies to raise, in aggregate, up to £30 million with over-allotment facilities of up to, in aggregate, a further £10 million (before issue costs) (the "Offers").

 

The Companies have also published a joint Circular (the "Circular") seeking the approval of their respective Shareholders for matters in connection with the Offers, each Company giving notice of a General Meeting to be held on 2 November 2018 (the "General Meeting").

 

The Offers will open on 26 September 2018 and the deadline for receipt of applications is 12.00 noon on 3 April 2019 in relation to the tax year 2018/19 and 12.00 noon on 26 April 2019 in relation to the tax year 2019/20. The Offers will close on 26 April 2019 unless the relevant Offer is fully subscribed by an earlier date or previously extended by the relevant Board to no later than 16 September 2019. Each Company intends to re-introduce its dividend investment scheme (DIS) with immediate effect. Applicants under the Offers can make a DIS election using the application form for the Offers. Full details of each Company's DIS, together with mandate forms are available from the relevant Company's website.

 

Each Offer is conditional on the passing of all the resolutions at the relevant General Meeting.

Pursuant to individual offer agreements dated 26 September 2018 relating to each Offer between, among others, each relevant Company and Maven Capital Partners LLP ("Maven"), Maven, as the administrator of the Offer, will receive an offer administration fee of 2.5% of the application amount in relation to each accepted application, with reductions to the fee applying in certain cases (for instance, early applications under the Offers). Maven as the investment manager of each Company is a related party of each Company under the Listing Rules, and the payment of such a fee by the Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

Maven VCT 1 has also agreed with Maven, subject to Shareholder approval on the terms set out in the Circular, to vary the terms of a management and administration deed entered into with Maven on 1 March 2015 (the "Deed"), with the effect that, from 1 March 2019, Maven's fee for secretarial services will increase from £50,000 to £100,000 per annum (excluding VAT, if any), the notice period under the Deed will be increased from six months to twelve months, and the cap on fees payable to Maven under the Deed will be removed. As Maven is a related party of Maven VCT 1 under the Listing Rules, the aggregate potential impact of the above changes to the terms of the management and administration deed between that Company and Maven is a transaction to which Listing Rule 11.1.10R applies.

The Maven VCT 1 Board composition is regularly reviewed by the Directors, and Fiona Wollocombe will step down from the Board at the end of the current financial year. Maven VCT 1 Shareholders will be informed when further information is available regarding the appointment of replacement or additional Directors.

To obtain a copy of the Securities Note, private investors and financial advisers should call Maven Capital Partners LLP on 0141 306 7400. A downloadable version of the Securities Note will also be available from each of the Company's websites: http://www.mavencp.com/migvct and http://mavencp.com/migvct5.

Copies of the Prospectus and Circular are available, free of charge, from Maven Capital Partners UK LLP at Kintyre House, 205 West George Street, Glasgow G2 2LW.

 

In accordance with the Listing Rules, the Prospectus and Circular have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM.

 

Any enquiries in respect of the Offers should be directed to:

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400E-mail: enquiries@mavencp.com 

 

Maven Capital Partners UK LLPSecretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRDQLFLVKFBBBV
Date   Source Headline
5th Apr 20243:49 pmRNSIssue of Equity
27th Mar 202410:31 amRNSIssue of Equity
22nd Mar 20244:25 pmRNSStatement re Offer for Subscription
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:48 pmRNSUnaudited Net Asset Value
8th Mar 20242:57 pmRNSAnnual Financial Report
15th Feb 20244:45 pmRNSTransaction in Own Shares
8th Feb 202410:33 amRNSDirector/PDMR Shareholding
8th Feb 202410:12 amRNSIssue of Equity
7th Feb 20243:09 pmRNSDividend Declaration
19th Dec 20233:28 pmRNSIssue of Equity
18th Dec 20235:24 pmRNSUnaudited Net Asset Value
9th Nov 20233:51 pmRNSResult of General Meeting
20th Oct 20234:13 pmRNSTransaction in Own Shares
13th Oct 20234:56 pmRNSPublication of a Prospectus
4th Oct 20234:03 pmRNSNet Asset Value(s)
29th Aug 20239:15 amRNSDirectorate Change
24th Jul 202311:16 amRNSHalf-year Report
21st Jul 20234:43 pmRNSTransaction in Own Shares
21st Jul 20239:48 amRNSIssue of Equity
17th Jul 202310:57 amRNSNet Asset Value - Dividend Investment Scheme
11th Jul 20234:47 pmRNSNet Asset Value
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
14th Jun 202310:33 amRNSDividend Declaration
2nd Jun 20239:48 amRNSIssue of Equity
5th May 202310:23 amRNSIssue of Equity - Dividend Investment Scheme
27th Apr 20233:57 pmRNSTransaction in Own Shares
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202311:39 amRNSNet Asset Value - Dividend Investment Scheme
25th Apr 20233:14 pmRNSNet Asset Value(s)
25th Apr 202312:50 pmRNSResult of AGM
5th Apr 202312:32 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
23rd Mar 20235:18 pmRNSAnnual Financial Report
3rd Mar 20239:56 amRNSIssue of Equity
21st Feb 20234:44 pmRNSTransaction in Own Shares
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 20239:48 amRNSIssue of Equity
1st Feb 20233:25 pmRNSUnaudited NAV and Proposed Final Dividend
9th Nov 20223:02 pmRNSResult of General Meeting
4th Nov 20223:25 pmRNSTransaction in Own Shares
26th Oct 20223:53 pmRNSTransaction in Own Shares
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
4th Oct 20221:35 pmRNSNet Asset Value(s)
26th Aug 202210:14 amRNSIssue of Equity
22nd Aug 20229:36 amRNSStatement re Dividend Investment Scheme
11th Aug 20224:47 pmRNSTransaction in Own Shares
25th Jul 20227:00 amRNSHalf-year Report
12th Jul 202212:40 pmRNSUnaudited Net Asset Value and Dividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.